Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill
NCT ID: NCT05243186
Last Updated: 2022-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
30 participants
INTERVENTIONAL
2021-10-01
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* While taking Methylphenidate and sitting at a desk
* While taking Methylphenidate and walking on a treadmill workstation
* Without taking Methylphenidate while sitting at a desk
* Without taking Methylphenidate while walking on a treadmill workstation The investigators will compare the cognitive achievements outcomes and evaluate the efficiency of studying in each of these four conditions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents
NCT05517785
The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
NCT02180529
The Effects of a Single Dose of Methylphenidate on Motor Performance
NCT04283604
Methylphenidate in Healthy Young Adults
NCT00815841
Further Studies of Attention Deficit Disorder - Residual Type (RT)
NCT00693212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MPH walking
The participants will be instructed to work while taking Methylphenidate and walking on a treadmill workstation
Treadmill workstation
walking on a treadmill workstation next to desk with computer and screen
Methylphenidate
Using prescription drug
MPH sitting
The participants will be instructed to work while taking Methylphenidate and sitting at a desk
Methylphenidate
Using prescription drug
No MPH walking
The participants will be instructed to work without taking Methylphenidate while walking on a treadmill workstation
Treadmill workstation
walking on a treadmill workstation next to desk with computer and screen
No MPH sitting
The participants will be instructed to work without taking Methylphenidate while sitting at a desk
Treadmill workstation
walking on a treadmill workstation next to desk with computer and screen
Methylphenidate
Using prescription drug
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treadmill workstation
walking on a treadmill workstation next to desk with computer and screen
Methylphenidate
Using prescription drug
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with ADHD by Neurologist/Psychiatrist/Developmental Doctor
* Take Methylphenidate as part of the treatment for ADHD AND have agreed to not take the drug if asked to
* Understand the language and simple instruction
* Willing to participate in the study and sign the agreement form
Exclusion Criteria
* Women who are pregnant
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maccabi Healthcare Services, Israel
OTHER
Ariel University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liat Korn, PhD
Role: PRINCIPAL_INVESTIGATOR
Ariel University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ariel University
Ariel, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Korn L, Hassan K, Fainshtein N, Yusov N, Davidovitch N. Non-Medical Use of Prescription Stimulants for Treatment of Attention Disorders by University Students: Characteristics and Associations. Med Sci Monit. 2019 May 21;25:3778-3787. doi: 10.12659/MSM.913973.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ArielUni
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.